Some patients with a rare disease face hurdles getting the only treatment
Bloomberg (subscription required): Mark Aulisio, the Susan E. Watson Professor and chair of the Department of Bioethics, discussed a pharmaceutical manufacturer’s drug that treats a genetic disorder that causes intense pain when sunlight hits a person’s skin. He shared concerns about the company’s lack of transparency. “It makes you worry that it’s more about competition,” he said.